Defence · Founded 1963 · www.hal-india.co.in · BSE 541154 · NSE HAL · ISIN INE066F01020
No Notes Added Yet
Business
Hindustan Aeronautics Ltd. (HAL) is a state-owned aerospace and defence company headquartered in Bengaluru, India. Its core business involves the design, development, manufacture, repair, overhaul, and upgrade of aircraft, helicopters, aero-engines, avionics, accessories, and aerospace structures. HAL primarily serves the Indian armed forces (Air Force, Navy, Army, Coast Guard) by supplying indigenous platforms and providing extensive maintenance, repair, and overhaul (MRO) services. It also undertakes R&D activities for future aerospace technologies. HAL makes money through the sale of new platforms, spare parts, upgrades, and MRO services, primarily under contracts with the Ministry of Defence.
Revenue Mix
HAL's operations are largely integrated across its various product lines and services rather than distinct revenue segments like a diversified conglomerate. Its primary operational areas include:
Manufacturing: Production of fixed-wing aircraft (e.g., Tejas LCA, Dornier Do-228), rotary-wing aircraft (e.g., Dhruv ALH, Chetak, Cheetah, LCH), aero-engines, and related avionics and accessories.
Maintenance, Repair & Overhaul (MRO): Comprehensive MRO services for its own manufactured platforms as well as various imported aircraft and helicopters operated by the Indian armed forces.
Design & Development: Research and development of new aerospace technologies and platforms, often in collaboration with defence research organizations.
Specific revenue contributions from each segment are not typically disclosed in granular detail, but manufacturing and MRO form the bulk of its revenue.
Industry
HAL operates in the highly strategic and regulated Indian defence aerospace industry. The industry is characterized by significant government procurement, high capital intensity, long development cycles, and a strong push for indigenization ("Make in India"). HAL holds a dominant, near-monopolistic position as the primary indigenous aircraft and helicopter manufacturer and MRO provider for the Indian armed forces. While private players are entering defence manufacturing, particularly in sub-systems and components, HAL remains the prime contractor for most major indigenous aerospace platforms, benefiting from government patronage and strategic importance.
MOAT
HAL possesses several durable competitive advantages:
Government Patronage & Strategic Importance: As a Public Sector Undertaking (PSU) and the sole indigenous prime contractor for many aerospace platforms, HAL benefits from a strategic relationship with the Indian Ministry of Defence, ensuring a consistent order pipeline.
High Entry Barriers: The defence aerospace sector requires immense capital investment, advanced technological know-how, long gestation periods, and stringent regulatory approvals, making it difficult for new entrants.
Indigenous Capability: HAL has unique R&D, design, and manufacturing capabilities for specific indigenous platforms (e.g., Tejas, Dhruv), giving it an irreplaceable role in India's defence self-reliance.
High Switching Costs: For defence platforms, the costs associated with switching suppliers are extremely high due to interoperability requirements, training, logistics, and integrated supply chains for spares and MRO.
Scale and Infrastructure: HAL has a vast manufacturing footprint, extensive MRO facilities, and a large skilled workforce, built over decades, which is difficult for competitors to replicate.
Growth Drivers
Increasing Defence Budgets & Modernization: Sustained increase in India's defence spending and the urgent need to modernize the aging fleets of the Indian Air Force, Navy, and Army.
"Make in India" & "Atmanirbhar Bharat" Initiatives: Government's strong emphasis on indigenous procurement and reducing reliance on foreign imports directly benefits HAL as the primary domestic aerospace manufacturer.
Fleet Expansion: Procurement plans for new platforms like LCA Tejas Mk2, Advanced Medium Combat Aircraft (AMCA), Light Combat Helicopters (LCH), and Light Utility Helicopters (LUH).
Growing MRO Demand: An expanding fleet of both indigenous and imported aircraft naturally leads to a higher demand for MRO services.
Export Potential: Opportunities to export indigenous platforms and MRO services to friendly foreign countries, leveraging geopolitical alignments.
Risks
Dependence on Government Orders: Over-reliance on the Ministry of Defence for orders makes HAL vulnerable to changes in defence procurement policies, budget cuts, or order deferrals.
Project Delays and Cost Overruns: Long gestation periods for defence projects, technological complexities, and supply chain issues can lead to delays and cost escalations.
Import Dependence: Despite indigenization efforts, HAL remains dependent on foreign suppliers for critical components, raw materials, and specific technologies, leading to potential supply chain risks and foreign exchange fluctuations.
Competition: While dominant, there is increasing government emphasis on private sector participation in defence, which could lead to competition in certain sub-systems or future projects.
Technological Obsolescence: Rapid advancements in aerospace technology require continuous R&D investment to remain competitive.
Geopolitical Risks: Global geopolitical tensions can impact supply chains, raw material costs, and export opportunities.
Management & Ownership
Hindustan Aeronautics Ltd. is a Public Sector Undertaking (PSU) with the majority stake owned by the Government of India. The management team comprises seasoned professionals appointed by the government, typically with extensive experience within the public sector and defence industry. The Government of India acts as the promoter, guiding the strategic direction and ensuring the company aligns with national defence objectives.
Outlook
HAL is strategically vital for India's national security and defence indigenization goals. It benefits significantly from the government's "Make in India" push and the ongoing modernization requirements of the Indian armed forces, which translate into a robust order pipeline. The company is well-positioned to capitalize on increasing defence budgets and the demand for indigenous platforms. However, HAL faces inherent challenges typical of a large public sector defence entity, including potential project execution delays, continued reliance on foreign components for certain technologies, and the cyclical nature of defence procurement. Efficient project management, timely deliveries, and continuous technological upgrades will be crucial for HAL to effectively leverage its dominant market position and sustain long-term growth.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 6061 | 14769 | 4348 | 5976 | 6957 | 13700 | 4819 | 6629 | 7699 | 13942 |
| Other Income | 460 | 557 | 736 | 542 | 631 | 652 | 747 | 888 | 914 | 1151 |
| Total Income | 6521 | 15326 | 5084 | 6519 | 7589 | 14351 | 5566 | 7516 | 8613 | 15093 |
| Total Expenditure | 4626 | 8867 | 3357 | 4336 | 5275 | 8405 | 3537 | 5071 | 5828 | 8884 |
| Operating Profit | 1895 | 6459 | 1727 | 2182 | 2314 | 5946 | 2029 | 2446 | 2785 | 6209 |
| Interest | 0 | 31 | 0 | 0 | 0 | 8 | 0 | 0 | 1 | 4 |
| Depreciation | 212 | 644 | 149 | 178 | 277 | 736 | 185 | 226 | 310 | 634 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1683 | 5783 | 1578 | 2011 | 2037 | 5202 | 1844 | 2220 | 2474 | 5571 |
| Provision for Tax | 428 | 1486 | 147 | 512 | 602 | 1242 | 471 | 558 | 620 | 1388 |
| Profit After Tax | 1255 | 4297 | 1431 | 1498 | 1434 | 3959 | 1373 | 1662 | 1854 | 4183 |
| Adjustments | 7 | 12 | 6 | 12 | 5 | 17 | 10 | 7 | 13 | 13 |
| Profit After Adjustments | 1261 | 4309 | 1437 | 1510 | 1440 | 3977 | 1384 | 1669 | 1867 | 4196 |
| Adjusted Earnings Per Share | 18.9 | 64.4 | 21.5 | 22.6 | 21.5 | 59.5 | 20.7 | 25 | 27.9 | 62.7 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 15939 | 16759 | 17950 | 18520 | 20008 | 21445 | 22882 | 24620 | 26927 | 30381 | 30981 | 33089 |
| Other Income | 1724 | 1932 | 1042 | 762 | 376 | 297 | 357 | 985 | 1670 | 1897 | 2562 | 3700 |
| Total Income | 17663 | 18691 | 18991 | 19282 | 20384 | 21742 | 23240 | 25605 | 28598 | 32278 | 33543 | 36788 |
| Total Expenditure | 13630 | 14621 | 14687 | 15071 | 15457 | 16531 | 17538 | 19204 | 20242 | 20630 | 21360 | 23320 |
| Operating Profit | 4033 | 4070 | 4304 | 4211 | 4927 | 5211 | 5701 | 6401 | 8356 | 11648 | 12183 | 13469 |
| Interest | 21 | 6 | 16 | 35 | 178 | 360 | 267 | 65 | 64 | 43 | 22 | 5 |
| Depreciation | 822 | 863 | 713 | 947 | 1025 | 999 | 1158 | 1111 | 1785 | 1407 | 1340 | 1355 |
| Exceptional Income / Expenses | 2 | 0 | 0 | 0 | 0 | 119 | 2 | 0 | 0 | 0 | 6 | 0 |
| Profit Before Tax | 3191 | 3213 | 3592 | 3243 | 3725 | 3979 | 4283 | 5225 | 6510 | 10225 | 10867 | 12109 |
| Provision for Tax | 792 | 1209 | 967 | 1252 | 1396 | 1096 | 1038 | 145 | 682 | 2604 | 2503 | 3037 |
| Profit After Tax | 2399 | 2004 | 2625 | 1990 | 2328 | 2883 | 3246 | 5080 | 5828 | 7621 | 8364 | 9072 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43 |
| Profit After Adjustments | 2399 | 2004 | 2625 | 1990 | 2329 | 2883 | 3246 | 5080 | 5828 | 7621 | 8364 | 9116 |
| Adjusted Earnings Per Share | 24.9 | 27.7 | 36.3 | 29.8 | 34.8 | 43.1 | 48.5 | 76 | 87.1 | 114 | 125.1 | 136.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 2% | 8% | 8% | 7% |
| Operating Profit CAGR | 5% | 24% | 19% | 12% |
| PAT CAGR | 10% | 18% | 24% | 13% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -15% | 39% | 53% | NA% |
| ROE Average | 26% | 27% | 27% | 22% |
| ROCE Average | 34% | 34% | 32% | 28% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 16804 | 11032 | 12559 | 9511 | 12082 | 13249 | 15424 | 19313 | 23572 | 29138 | 34982 |
| Minority's Interest | 0 | 0 | 0 | -0 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Borrowings | 107 | 0 | 0 | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 11899 | 12849 | 13401 | 11981 | 10075 | 8427 | 10871 | 13487 | 11675 | 11175 | 25618 |
| Total Current Liabilities | 35528 | 32650 | 25585 | 26097 | 28193 | 31127 | 25413 | 25023 | 30827 | 36324 | 44095 |
| Total Liabilities | 64339 | 56532 | 51545 | 47689 | 50454 | 52807 | 51712 | 57826 | 66078 | 76641 | 104699 |
| Fixed Assets | 7366 | 6549 | 7350 | 7566 | 7459 | 7357 | 7166 | 6766 | 6834 | 6737 | 6671 |
| Other Non-Current Assets | 2014 | 4257 | 4020 | 3108 | 3347 | 4056 | 4168 | 6068 | 7359 | 6886 | 7933 |
| Total Current Assets | 54959 | 45726 | 40176 | 37015 | 39648 | 41394 | 40378 | 44985 | 51877 | 63017 | 90095 |
| Total Assets | 64339 | 56532 | 51545 | 47689 | 50454 | 52807 | 51712 | 57826 | 66078 | 76641 | 104699 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 11238 | 1729 | 334 | 2804 | 107 | 27 | 279 | 7146 | 3070 | 4441 | 4255 |
| Cash Flow from Operating Activities | -8882 | 3148 | -405 | -748 | -7700 | 1527 | 15117 | 10173 | 8830 | 8223 | 13643 |
| Cash Flow from Investing Activities | 710 | 1347 | 3012 | 597 | 5294 | -1339 | -1180 | -12785 | -5728 | -6410 | -10771 |
| Cash Flow from Financing Activities | -1274 | -5880 | -164 | -2540 | 2326 | 64 | -7070 | -1464 | -1731 | -1999 | -2579 |
| Net Cash Inflow / Outflow | -9446 | -1385 | 2443 | -2691 | -80 | 252 | 6867 | -4076 | 1370 | -186 | 294 |
| Closing Cash & Cash Equivalent | 1792 | 344 | 2777 | 113 | 27 | 279 | 7146 | 3070 | 4441 | 4255 | 4549 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 24.89 | 27.72 | 36.3 | 29.76 | 34.82 | 43.11 | 48.54 | 75.96 | 87.14 | 113.95 | 125.07 |
| CEPS(Rs) | 33.42 | 39.66 | 46.16 | 43.92 | 50.15 | 58.03 | 65.84 | 92.56 | 113.83 | 134.99 | 145.11 |
| DPS(Rs) | 4.98 | 8.7 | 11.05 | 16.1 | 9.9 | 16.5 | 15 | 25 | 27.5 | 35 | 40 |
| Book NAV/Share(Rs) | 174.32 | 152.59 | 173.71 | 142.22 | 180.66 | 198.1 | 230.63 | 288.78 | 352.46 | 435.69 | 523.07 |
| Core EBITDA Margin(%) | 14.48 | 12.46 | 17.59 | 18.52 | 22.75 | 22.92 | 23.35 | 22 | 24.83 | 32.1 | 31.05 |
| EBIT Margin(%) | 20.15 | 18.76 | 19.45 | 17.6 | 19.5 | 20.23 | 19.89 | 21.49 | 24.41 | 33.8 | 35.15 |
| Pre Tax Margin(%) | 20.02 | 18.73 | 19.36 | 17.41 | 18.62 | 18.55 | 18.72 | 21.22 | 24.17 | 33.66 | 35.08 |
| PAT Margin (%) | 15.05 | 11.68 | 14.15 | 10.69 | 11.64 | 13.44 | 14.18 | 20.63 | 21.64 | 25.08 | 27 |
| Cash Profit Margin (%) | 20.21 | 16.71 | 17.99 | 15.77 | 16.76 | 18.1 | 19.24 | 25.14 | 28.27 | 29.72 | 31.32 |
| ROA(%) | 3.73 | 3.32 | 4.86 | 4.01 | 4.74 | 5.58 | 6.21 | 9.28 | 9.41 | 10.68 | 9.22 |
| ROE(%) | 14.28 | 14.4 | 22.25 | 18.04 | 21.57 | 22.76 | 22.64 | 29.25 | 27.18 | 28.92 | 26.09 |
| ROCE(%) | 18.91 | 22.91 | 29.22 | 27.31 | 29.28 | 24.5 | 26.26 | 30.37 | 30.59 | 38.89 | 33.91 |
| Receivable days | 144.42 | 118.53 | 89.09 | 107.51 | 175.22 | 201.63 | 134.81 | 76.42 | 63.44 | 56.08 | 54.58 |
| Inventory Days | 576.77 | 522.98 | 445.63 | 398.61 | 355.93 | 332.75 | 287.99 | 229.94 | 179.58 | 152.38 | 205.55 |
| Payable days | 102.62 | 95.2 | 73.86 | 67.39 | 88.72 | 130.51 | 103.38 | 87.83 | 102.84 | 108.05 | 126.52 |
| PER(x) | 0 | 0 | 0 | 18.96 | 10.19 | 6.18 | 10.25 | 9.79 | 15.67 | 29.2 | 33.39 |
| Price/Book(x) | 0 | 0 | 0 | 3.97 | 1.96 | 1.35 | 2.16 | 2.57 | 3.87 | 7.64 | 7.98 |
| Dividend Yield(%) | 0 | 0 | 0 | 2.85 | 2.79 | 6.19 | 3.02 | 3.36 | 2.01 | 1.05 | 0.96 |
| EV/Net Sales(x) | -1.07 | -0.77 | -0.54 | 1.73 | 1.39 | 1.09 | 1.14 | 1.44 | 2.64 | 6.46 | 7.78 |
| EV/Core EBITDA(x) | -4.24 | -3.16 | -2.27 | 7.62 | 5.64 | 4.5 | 4.58 | 5.53 | 8.5 | 16.84 | 19.79 |
| Net Sales Growth(%) | 0 | 5.14 | 7.11 | 3.17 | 8.04 | 7.18 | 6.7 | 7.59 | 9.37 | 12.83 | 1.97 |
| EBIT Growth(%) | 0 | 0.21 | 12.08 | -9.17 | 19.07 | 11.17 | 4.89 | 16.25 | 24.28 | 56.19 | 6.05 |
| PAT Growth(%) | 0 | -16.45 | 30.96 | -24.18 | 16.99 | 23.81 | 12.59 | 56.52 | 14.72 | 30.77 | 9.75 |
| EPS Growth(%) | 0 | 11.4 | 30.96 | -18.02 | 16.99 | 23.8 | 12.6 | 56.5 | 14.72 | 30.77 | 9.75 |
| Debt/Equity(x) | 0.01 | 0.01 | 0.08 | 0.1 | 0.34 | 0.45 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 1.55 | 1.4 | 1.57 | 1.42 | 1.41 | 1.33 | 1.59 | 1.8 | 1.68 | 1.73 | 2.04 |
| Quick Ratio(x) | 0.84 | 0.67 | 0.74 | 0.68 | 0.71 | 0.71 | 0.93 | 1.22 | 1.29 | 1.37 | 1.55 |
| Interest Cover(x) | 149.49 | 545.63 | 219.34 | 94.66 | 21.97 | 12.06 | 17.05 | 81.08 | 102.06 | 240.85 | 503.65 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0.02 | 0.18 | 0.33 | 0 | 0 | 0 | 0 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 71.64 | 71.64 | 71.64 | 71.64 | 71.64 | 71.64 | 71.64 | 71.64 | 71.64 | 71.64 |
| FII | 12.94 | 12.42 | 11.68 | 11.85 | 12.26 | 12.08 | 11.9 | 12 | 10.86 | 10.2 |
| DII | 9.14 | 9.57 | 8.81 | 8.38 | 8.15 | 8.3 | 8.73 | 8.71 | 9.74 | 10.5 |
| Public | 6.29 | 6.37 | 7.87 | 8.13 | 7.95 | 7.98 | 7.73 | 7.65 | 7.76 | 7.65 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 47.91 | 47.91 | 47.91 | 47.91 | 47.91 | 47.91 | 47.91 | 47.91 | 47.91 | 47.91 |
| FII | 8.65 | 8.31 | 7.81 | 7.93 | 8.2 | 8.08 | 7.96 | 8.03 | 7.26 | 6.82 |
| DII | 6.11 | 6.4 | 5.89 | 5.6 | 5.45 | 5.55 | 5.84 | 5.83 | 6.51 | 7.02 |
| Public | 4.21 | 4.26 | 5.26 | 5.44 | 5.32 | 5.34 | 5.17 | 5.11 | 5.19 | 5.12 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 66.88 | 66.88 | 66.88 | 66.88 | 66.88 | 66.88 | 66.88 | 66.88 | 66.88 | 66.88 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +2% | +8% | +8% | +7% |
| Operating Profit CAGR | +5% | +24% | +19% | +12% |
| PAT CAGR | +10% | +18% | +24% | +13% |
| Share Price CAGR | -15% | +39% | +53% | — |
| ROE Average | +26% | +27% | +27% | +22% |
| ROCE Average | +34% | +34% | +32% | +28% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 71.64 | 71.64 | 71.64 | 71.64 | 71.64 | 71.64 | 71.64 | 71.64 | 71.64 | 71.64 |
| FII | 12.94 | 12.42 | 11.68 | 11.85 | 12.26 | 12.08 | 11.9 | 12 | 10.86 | 10.2 |
| DII | 9.14 | 9.57 | 8.81 | 8.38 | 8.15 | 8.3 | 8.73 | 8.71 | 9.74 | 10.5 |
| Public | 28.36 | 28.36 | 28.36 | 28.36 | 28.36 | 28.36 | 28.36 | 28.36 | 28.36 | 28.36 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 47.91 | 47.91 | 47.91 | 47.91 | 47.91 | 47.91 | 47.91 | 47.91 | 47.91 | 47.91 |
| FII | 8.65 | 8.31 | 7.81 | 7.93 | 8.2 | 8.08 | 7.96 | 8.03 | 7.26 | 6.82 |
| DII | 6.11 | 6.4 | 5.89 | 5.6 | 5.45 | 5.55 | 5.84 | 5.83 | 6.51 | 7.02 |
| Public | 18.97 | 18.97 | 18.97 | 18.97 | 18.97 | 18.97 | 18.97 | 18.97 | 18.97 | 18.97 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 66.88 | 66.88 | 66.88 | 66.88 | 66.88 | 66.88 | 66.88 | 66.88 | 66.88 | 66.88 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.